Herb

    Oregon Grape

    Mahonia aquifolium

    TL;DR

    Oregon grape is a berberine-containing root used mainly as a topical for psoriasis, where small trials show modest plaque improvement. Oral use carries the same berberine interaction problems without the same evidence.

    Ideal For

    • People with mild plaque psoriasis wanting a topical adjunct
    • Those already using a dermatologist-supervised regimen

    Avoid If

    • You are pregnant or breastfeeding
    • You are giving it to an infant, due to bilirubin displacement risk
    • You take drugs metabolised by CYP3A4
    • You have liver disease

    Frequently Asked Questions

    What is Oregon grape?
    Mahonia aquifolium root, a berberine-containing herb used traditionally for digestive complaints and, topically, for psoriasis.
    Does it help psoriasis?
    Topical 10 percent cream has the best support, with several trials reporting mild to moderate improvement in plaque psoriasis. Oral evidence is much weaker.
    Is it the same as berberine?
    It contains berberine, but at low and variable levels. It is a poor way to reach the doses used in metabolic trials.
    What dose is used orally?
    Traditional use is around 500 mg of dried root up to three times daily, or a tincture equivalent. No effective dose is established.
    Does it interact with medicines?
    Yes. Berberine-containing herbs inhibit CYP3A4 and P-glycoprotein, altering levels of statins, ciclosporin and many other drugs.
    Who must avoid it?
    People who are pregnant or breastfeeding, and newborns - berberine can displace bilirubin. Also avoid it with jaundice or liver disease.

    Overview

    Oregon grape (Mahonia aquifolium) contains berberine, berbamine and oxyacanthine. Its best-supported use is topical: 10 percent Mahonia cream applied twice daily has been compared with placebo and with calcipotriol in small psoriasis trials, producing meaningful but smaller improvements than the prescription comparator, with good tolerability. A handful of open-label studies report reduced PASI scores over 12 weeks. Oral use is traditional for digestive complaints and infections, but the human evidence is essentially absent and the berberine content brings the same concerns that apply to berberine itself, including CYP3A4 inhibition and displacement of bilirubin, which is why it is contraindicated in newborns and pregnancy. Treat oral Oregon grape as an inferior, less standardised route to berberine.

    How It Works

    • Berberine alkaloids inhibit keratinocyte hyperproliferation, relevant to psoriasis plaques
    • Inhibits lipoxygenase, reducing inflammatory leukotriene production
    • Antimicrobial activity against several bacteria and fungi in vitro
    • Berberine inhibits CYP3A4, the source of most interaction risk

    Benefits & Outcomes

    No linked outcomes yet. Research is ongoing.

    Supporting Research
    5 studies

    Plant extracts for the topical management of psoriasis: a systematic review and meta-analysis

    Score: 7/10
    2013
    meta_analysis

    Deng S, May BH, Zhang AL +2 more

    Topical Mahonia aquifolium showed benefit for psoriasis severity, but the evidence was of low methodological quality.

    View source

    Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension

    Score: 7/10
    2015
    meta_analysis
    n=2569

    Lan J, Zhao Y, Dong F +4 more

    Berberine, the main alkaloid in Oregon grape, lowered fasting glucose and HbA1c in pooled trials.

    View source

    Berberine and barberry (Berberis vulgaris): A clinical review

    Score: 6/10
    2019
    systematic_review

    Imenshahidi M, Hosseinzadeh H

    Berberine-containing botanicals inhibit CYP3A4 and are contraindicated in pregnancy and in neonates.

    View source

    Mahonia aquifolium in patients with psoriasis vulgaris: an intra-individual study

    Score: 4/10
    1999
    rct
    n=82

    Augustin M, Andrees U, Grimme H +2 more

    Mahonia ointment was less effective than dithranol but better tolerated in plaque psoriasis.

    View source

    A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis

    Score: 3/10
    2005
    observational
    n=200

    Gulliver WP, Donsky HJ

    Most patients using Mahonia ointment for 12 weeks reported improvement in psoriasis severity.

    View source

    Safety Information

    Potential Side Effects

    Topical: burning, itching or rash in a minority. Oral: GI upset, nausea. Berberine alkaloids can cause diarrhoea and cramping.

    Contraindications

    Pregnancy, lactation, neonates and infants; concurrent CYP3A4-dependent medication.

    Drug Interactions

    • Inhibits CYP3A4, raising levels of statins, ciclosporin and many others
    • May add to the glucose-lowering effect of antidiabetic drugs
    • Displaces bilirubin from albumin, dangerous in neonates

    Pregnancy & Breastfeeding

    Pregnancy: Likely unsafe

    Breastfeeding: Likely unsafe

    Dosage Guidelines

    Dosage Used in Studies

    Consult healthcare provider

    Dosing by Goal

    GoalDoseNotes
    Topical10% cream applied twice daily to plaques for up to 12 weeks
    Oral traditionalTincture 1-2 mL up to three times daily; not evidence-based
    NotesIf the goal is a berberine effect, use standardised berberine HCl instead

    Forms Compared

    10% topical cream

    The format with actual psoriasis trial data

    Root tincture

    Traditional oral use; unstandardised alkaloid content

    Dried root capsules

    No meaningful human evidence for oral use

    Food & Timing

    Topical use is unaffected by food. Oral tincture is traditionally taken before meals.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.